Avantax Planning Partners’s Array Biopharma Inc ARRY Stock Holding History

Avantax Planning Partners’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,331	Closed	-$297K	–	313
2019 Q2	$297K	Buy	+6,331	New	+$178K	0.02%	231
2018 Q4	–	Sell	-6,305	Closed	-$96K	–	1412
2018 Q3	$96K	Buy	+6,305	New	+$96.6K	0.01%	355
2018 Q2	–	Sell	-6,305	Closed	-$103K	–	1769
2018 Q1	$103K	Buy	+6,305	New	+$101K	0.01%	404

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Avantax Planning Partners's ARRY Position: Q3 2019 in Review

Avantax Planning Partners sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 6,331 shares — an estimated $297K sold.

Avantax Planning Partners first reported a position in ARRY in Q1 2018 and held it in 3 quarters. The position peaked at $297K in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Avantax Planning Partners reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Avantax Planning Partners sold 6,331 Array Biopharma Inc shares in Q3 2019, an estimated $297K.
Avantax Planning Partners first reported a position in Array Biopharma Inc in Q1 2018 and held it in 3 quarters.
Avantax Planning Partners's Array Biopharma Inc position peaked at $297K in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Avantax Planning Partners's 13F filing for Q3 2019, filed 8 Nov 2019.